Citius Oncology, Inc.
CTORHealthcare|Medical - Pharmaceuticals|US
$0.51
+0.01 (+1.88%)
DCF Value
$0.10
Cash / Share
$0.15
About
Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Stock Price
-64.6%(1Y)
1M
-39.0%
3M
-32.3%
6M
-43.8%
YTD
-49.0%
1Y
-64.4%
3Y
-95.5%
5Y
-95.5%
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Key Facts
Market Cap$47.4M
Employees0
CEOLeonard L. Mazur
IPO DateDec 8, 2022
Beta3.58
52-Week Range$0.491 – $1.83
Avg Volume110,198
ExchangeNASDAQ
Ownership
Float19.1%
Shares Outstanding93.0M
Recent Insider Trades
Peri JonathanOTHER
Aug 10, 20260 shares
HOLUBIAK MYRON ZAWARD
Sep 19, 2025850,000 shares
HOLUBIAK MYRON ZAWARD
Sep 19, 2025100,000 shares
Smith Robert JosephAWARD
Sep 19, 2025300,000 shares
Mazur Leonard LAWARD
Sep 19, 20251,700,000 shares
Peers
Recent News
Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe
Nov 4, 2026 · prnewswire.com
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Oct 26, 2026 · gurufocus.com
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Oct 26, 2026 · prnewswire.com
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Oct 12, 2026 · prnewswire.com
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
Sep 3, 2026 · prnewswire.com
Data last updated: Nov 9, 2026, 04:05 AM